Creese A., Kutzin J., Lessons from cost recovery in health, WHO/SHS/NHP95.5. World Health Organization, Geneva 1995.

Van Adams A., Harnett T., Cost-sharing in the social sector of sub-saharah africa: impact on the poor, World Bank Discussion Paper No. 338: African technical Department Series, Washington 1996.

Abel-Smith B., Global perspectives on health service financing, „Social Science and Medicine” 1985; 21, 9: 957–963.

Ros C.C., Groenewegen P.P., Delnoij D.M.J., All rights reserved, or can we just copy? Cost-sharing arrangements and characteristics of health care systems, „Health Policy” 2000; 52: 1–13.

Robinson R., User charges for health care, w: Mossialos E. i wsp. (red.), Funding health care: options for Europe, Open University Press, Buckingham 2002, 161–183.

Thomson S., Mossialos E., Jemiai N., Cost sharing for health services in the European Union, Report prepared for the European Commission, Directorate General for Employment and Social Affairs 2003.

Sowada C., Współpłacenie – szanse, zagrożenia i warunki szerszego zastosowania w systemie powszechnego społecznego ubezpieczenia zdrowotnego, „Zeszyty Naukowe Ochrony Zdrowia” 2004; II, 1: 11–22.

Rubin R., Mendelson D., A framework for cost-sharing analysis, w: Mattison N. (red.), Sharing the Costs of Health: a Multi-country Perspective, harmaceutical Partners for Better Health, Balse 1995.

Akerlof G.A., The Market for Lemons: Quality, Uncertainty and the Market Mechanism, „Quarterly Journal of Economics” 1970; 84, 3: 488–500.

Rice T., Morrison K.R., Patient cost-sharing for medical services: a review of the literature and implications for health care reform, „Medical Care Review” 1994: 51, 3: 239.

Muraro G., The role of price in the public health care service, w: Vigro J.M. (red.), Restructuring health policy: an international challenge, Edwardsville, IL: IHEMI 1986, 203–234.

World Health Organization, European health care reforms: analysis of current strategies, WHO/Regional Office for Europe, Copenhagen 1996.

Musgrove P., What should consumer in poor countries pay for publicity-provided health services, „Social Science and Medicine” 1986: 22, 3: 329–333.

Street A., Jones A., Futura A., Cost-sharing and pharmaceutical utilization in Russia: evidence from a household survey, Centre for Health Economics: Discussion Paper No. 155, University of York 1997.

Boaz R.F., Equity in paying for health care services under a national insurance system, MMFQ/„Health and Society” 1975, 337–352.

General Accounting Office, Prescription drugs and the elderly may still receive potentially harmful drugs despite recent improvements, GAO/PEMD 1995, 95–152.

Hurley J., Johnson N.A., The effects of co-payments within drug reimbursement programs, „Canadian Public Policy” 1992; 17, 4: 473–489.

Borowitz M., Massoud R., Mckee M., Improving the quality of health systems, w: Figueras J., McKee M., Cain J., Lessof S. (red.), Health systems in transition: learning from experience, European Observatory on Health Systems and Policies, Copenhagen 2004, 103–123.

Jacobzone S., Pharmaceutical Policies in OECD countries: reconciling social and industrial goals, OECD: Labour Market and Social Policy occasional papers 2000, nr 40.

Kanavos P., Pharmaceutical policies and proposals for pharmaceutical sector reform in Poland, London School of Economics and Political Science, London 2003.

Folland S., Goodman A.C., Stano M., The Economics of Health and Health Care – Fourth Edition, Pearson Prentice Hall, Upper Saddle River 2003.

European Federation of Pharmaceutical Industries and Associations, The Pharmaceutical Industry in Figures, EFPIA, Brussels 2008, 21–23.

Kuta W., Refundacja nad Sekwaną, czyli warto negocjować, „Rynek Zdrowia” 2008; 4, 33: 15–28.

Bundesministerium für Arbeit und Soziales, Sozial-Kompas Europa – Soziale sicherheit in Europa im Vergleich, Bonn 2007.

Georgieva L., Salchev P., Dimitrova R., Dimova A., Avdeeva O., Bulgaria – health system review, „Health System in Transition” 2007; 9, 1 [Dok. elektr.] http://www.euro.who.int/Document/E90023.pdf (20.01.2009).

World Health Organization, Approaching health financing policy in the WHO European Region, EUR/RC56/BD/1WHO/Regional Committee for Europe (fifty-sixth session:11–14 September 2006), Copenhagen 2006.

Organization for Economic Co-operation and Development, OECD Health Data 2007 – Pharmaceutical market,

Zeszyty Naukowe Ochrony Zdrowia. Zdrowie Publiczne i Zarządzanie finansowanie http://www.ecosante.org/index2.php?base=OCDE&langh=ENG&langs=ENG&sessionid= (20.01.2009).

Kaló Z., Docteur E., Moďsse P., Pharmaceutical pricing and reimbursement policies in Slovakia, OECD Health Working papers no. 31, Directorate for Employment, Labour and Social Affairs 2008.

Koppel A., Kahur K., Habicht T., Saar P., Habicht J., Van Ginneken E., Estonia – health system review, „Health Systems in Transition” 2008; 10, 1, http://www.euro.who.int/document/e91372.pdf (20.01.2009).

The Association of the British Pharmaceutical Industry, Facts and Statistics from the pharmaceutical industry – a global industry, http://www.abpi.org.uk/statistics/section.asp?sect=1 (20.01.2009).

Brenna A., Grossi M., Lucioni C., L’effetto del ticket moderateur sui farmaci: presupposti economici ed analisi statistica, La Goliardica, Pavia 1984.

Hanua C., Rizzi D., Econometria dei provvedimenti pubblicisull’assistenza farmaceutica: il caso dell’Emilia Romagna, „Economia Pubblica” 1986; 3: 177–183.

Scheiber R., Medea A., A curmudgeon’s guide to financing health care in developing countries, w: Scheiber G. (red.), Innovations in health care financing, World Bank, Washington DC 1997, 82–98.

Pavlova M., Groot W., Van Marode G., Willingness and ability of Bulgarian consumers to pay for improved public health care services, „Applied Economics” 2004; 36: 1117–1130.

World Health Organization, European health care reforms: analysis of current strategies, WHO/Regional Office for Europe, Copenhagen 1996.

Bennet S., Ngalande-Banda E., Public and private roles of in health: a review and analysis of experience in subsaharan Africa, WHO/ARA/CC97.6, Geneva 1997.

Creese A., User charges for health care: a review of recent experiences, „Health Policy and Planing” 1991; 6: 309–319.

Thompson R., Witter, S., Informal payments in transitional economies: implications for health sector reform, „International Journal of Health Planning and Management” 2000; 15: 169–187.

Randal E., The European Union and Health Policy, Palgrave Publishers, Houdmils and New York 2001.